Latest return on equity
SAB Biotherapeutics Return on equity
Direct answer
SAB Biotherapeutics's return on equity is -11.27%.
The verified market snapshot reports -11.27%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 12, 2026.
Get free SAB Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -11.27%